Kearns & Associates’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Hold
720
0.11% 38
2026
Q1
$237K Sell
720
-190
-21% -$68.2K 0.13% 38
2025
Q4
$320K Sell
910
-50
-5% -$18.2K 0.17% 36
2025
Q3
$355K Hold
960
0.19% 35
2025
Q2
$380K Hold
960
0.22% 34
2025
Q1
$357K Hold
960
0.23% 33
2024
Q4
$346K Hold
960
0.22% 35
2024
Q3
$347K Hold
960
0.23% 32
2024
Q2
$327K Hold
960
0.24% 30
2024
Q1
$344K Hold
960
0.27% 29
2023
Q4
$287K Hold
960
0.25% 31
2023
Q3
$262K Hold
960
0.25% 33
2023
Q2
$293K Hold
960
0.27% 29
2023
Q1
$274K Hold
960
0.27% 29
2022
Q4
$235K Buy
+960
New +$218K 0.25% 37

Other funds holding SYK

Kearns & Associates's SYK Position: Q2 2026 in Review

Kearns & Associates held its Stryker (SYK) position steady in Q2 2026 at 720 shares worth $227K. The position accounts for 0.11% of the portfolio, ranked #38.

Kearns & Associates first reported a position in SYK in Q4 2022 and has held it in 15 quarters since. The position peaked at $380K in Q2 2025. 764 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Kearns & Associates held 720 shares of Stryker worth $227K as of Q2 2026.
  • Kearns & Associates left its Stryker share count unchanged in Q2 2026.
  • Stryker made up 0.11% of Kearns & Associates's portfolio in Q2 2026, its #38 holding.
  • Kearns & Associates first reported a position in Stryker in Q4 2022 and has held it in 15 quarters since.
  • Kearns & Associates's Stryker position peaked at $380K in Q2 2025.
  • 764 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Kearns & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.